Trials / Completed
CompletedNCT01751022
Attain Performa(TM) Quadripolar Lead Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,202 (actual)
- Sponsor
- Medtronic Cardiac Rhythm and Heart Failure · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate the safety and efficacy of the Medtronic Attain Performa Quadripolar Leads (Model 4298, 4398, and 4598) during and post the implant procedure. This study will also assess the interactions of the Attain Performa leads with the entire Medtronic CRT-D system.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Device: Attain Performa Pacing Lead (along with a standard CRT-D system) | Implant and follow-up of study lead, separate analysis for each lead model |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2015-02-01
- Completion
- 2015-02-01
- First posted
- 2012-12-17
- Last updated
- 2016-12-05
- Results posted
- 2016-12-05
Locations
121 sites across 27 countries: United States, Australia, Austria, Belgium, Canada, Chile, Denmark, Finland, France, Germany, Greece, Hungary, India, Israel, Italy, Malaysia, Netherlands, Norway, Romania, Saudi Arabia, Serbia, Slovakia, Slovenia, South Africa, Spain, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT01751022. Inclusion in this directory is not an endorsement.